MoneyWorks4Me

SMS Lifesciences India informs about statement of investor complaints

11 Jan 2018 Evaluate

SMS Lifesciences India has informed about Statement of investor complaints for the quarter ended 31st December 2017 pursuant to reg.13(3) of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..